Etomidate Liposomal Injection from Canada
Advanced liposomal formulation of etomidate reducing injection site pain, in 20mL vials. Classified HTS 3004.90.92.37 as mixed product containing etomidate for measured sedative-hypnotic CNS therapy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Provide liposome size distribution and encapsulation efficiency certificates
• Ensure glass vial compatibility with lipid carriers
• Monitor for cold chain breaks affecting liposome stability